From November 13 to 16, MEDICA 2023 was held in Düsseldorf, Germany. This is the third consecutive year that YanengBIO has participated in this important medical equipment exhibition.

As a leading molecular diagnostic company from China, YanengBIO internationally launched YN-AHR3210 fully automated integrated nucleic acid testing system for the first time at this time. Utilizing PCR-reverse dot hybridization technology, this fully automated solution streamlines sample pre-treatment, PCR amplification, molecular hybridization, and result analysis, providing efficient "sample in, result out" testing. The system's automation, ease of use, and efficient detection have garnered the attention of both new and existing customers, attracting their curiosity to learn more.

YanengBIO also presented cervical cancer screening, DNA methylation testing, and SMA genetic testing products at the event. The high-quality products and services impressed numerous customers and reinforced the company's presence in the global market.

During the expo, YanengBIO engaged with new and existing clients to explore the future of molecular diagnostics and industry trends. These discussions are valuable resources for optimizing our products and aligning with customer requirements. YanengBIO aims to consistently provide exceptional molecular diagnostic solutions to our valued customers. We eagerly anticipate further collaborations and interactions both domestically and internationally.

See you next year!